Enrico Benedetti

Enrico Benedetti

Auto-generated profile, based on publicly available information

Enrico Benedetti

Division of Transplantation, Department of Surgery, University of Illinois Chicago, Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2002 in Transplantation
Verified
Journal Article
Closed access
SHSantiago Horgan
Santiago Horgan
DVDaniel Vanuno
Daniel Vanuno
PSPierpaolo Sileri
Pierpaolo Sileri
LCLuca Cicalese
Luca Cicalese
EBEnrico Benedetti
Enrico Benedetti
Minimally invasive laparoscopic nephrectomy is a well-established alternative to open surgery in living donors for kidney transplantation. Donor mortality and morbidity rates as well as recipient outcome are comparable to the open approach. Furthermore, the procedure is associated with reduced donor discomfort, faster recovery, and improved cosmetic results. Recently, an advanced robotic system for laparoscopic surgery was approved for use in the United States. This system allows a greater freedom of movement and recreates the hand–eye coordination and three-dimensional vision that is lost in standard laparoscopic procedures. We report the first 12 successful cases of robotic-assisted laparoscopic living donor nephrectomy performed using the da Vinci Surgical System (Intuitive Surgical, Mountain View, CA). Our initial experience has shown that the system allows the performance of donor nephrectomy in a safe and accurate fashion. As technology continues to evolve, robotic-assisted surgery has the potential to become a widely used attractive alternative to standard laparoscopic donor nephrectomy.

10 July 2021 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
UBUgo Boggi
Ugo Boggi
FVFabio Vistoli
Fabio Vistoli
AAAxel Andres
Axel Andres
HAHelmut P. Arbogast
Helmut P. Arbogast
LBLionel Badet
Lionel Badet
TBThierry Berney
Thierry Berney
The First World Consensus Conference on Pancreas Transplantation provided 49 jury deliberations regarding the impact of pancreas transplantation on the treatment of diabetic patients, and 110 experts’ recommendations for the practice of pancreas transplantation. The main message from this consensus conference is that both simultaneous pancreas-kidney transplantation (SPK) and pancreas transplantation alone can improve long-term patient survival, and all types of pancreas transplantation dramatically improve the quality of life of recipients. Pancreas transplantation may also improve the course of chronic complications of diabetes, depending on their severity. Therefore, the advantages of pancreas transplantation appear to clearly surpass potential disadvantages. Pancreas after kidney transplantation increases the risk of mortality only in the early period after transplantation, but is associated with improved life expectancy thereafter. Additionally, preemptive SPK, when compared to SPK performed in patients undergoing dialysis, appears to be associated with improved outcomes. Time on dialysis has negative prognostic implications in SPK recipients. Increased long-term survival, improvement in the course of diabetic complications, and amelioration of quality of life justify preferential allocation of kidney grafts to SPK recipients. Audience discussions and live voting are available online at the following URL address: http://mediaeventi.unipi.it/category/1st-world-consensus-conference-of-pancreas-transplantation/246.

19 July 2004 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
TJTomasz Jarzembowski
Tomasz Jarzembowski
EJEunice John
Eunice John
FPFabrizio Panaro
Fabrizio Panaro
JHJonathan Heiliczer
Jonathan Heiliczer
KKKerri Kraft
Kerri Kraft
EBEnrico Benedetti
Enrico Benedetti

5 July 2005 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
DBDiego Bogetti
Diego Bogetti
HSHoward N Sankary
Howard N Sankary
TJTomasz M Jarzembowski
Tomasz M Jarzembowski
AMAntonio Manzelli
Antonio Manzelli
PKPeter S Knight
Peter S Knight
EBEnrico Benedetti
Enrico Benedetti

1 November 2004 in Annals of Surgery
Verified
Journal Article
Closed access
GTGiuliano Testa
Giuliano Testa
FPFabrizio Panaro
Fabrizio Panaro
SSStefano Schena
Stefano Schena
MHMark Holterman
Mark Holterman
HAHerand Abcarian
Herand Abcarian
EBEnrico Benedetti
Enrico Benedetti
Objective: To describe a standardized technique for ileal graft procurement in the setting of living related bowel transplantation. Summary Background Data: Living donor transplantation has been successfully developed for kidney, liver, pancreas, and lung transplantation. More recently, living related small bowel transplantation (LR-SBTx) has been developed with the aim of expanding the pool of intestinal graft donors and reducing the mortality in patients on the waiting list. To date, a total of 25 LR-SBTx worldwide have been reported to the international registry. We herein report the largest single center experience. Methods: A segment of ileum, 150 to 200 cm, is resected 20 cm proximal to the ileocecal valve (ICV), which is always preserved. The arterial inflow is given by the terminal branch of the superior mesenteric artery and venous outflow by a proximal segment of the superior mesenteric vein. The entire bowel is measured intraoperatively and at least 60% of intestine length is left in the donor. Results: Since 1998, we have performed 9 terminal ileum resections for small bowel donation. None of the donors has experienced persistent alteration of bowel habits or malabsorption; only 1 minor wound complication has occurred. Conclusions: Terminal ileal resection with preservation of the ICV seems to assure fast functional recovery of the donor and has minimal postoperative complications.

1 November 2006 in Annals of Surgery
Verified
Journal Article
Closed access
EBEnrico Benedetti
Enrico Benedetti
MHMark Holterman
Mark Holterman
MAMassimo Asolati
Massimo Asolati
SDStefano Di Domenico
Stefano Di Domenico
JOJosé Oberholzer
José Oberholzer
GTGiuliano Testa
Giuliano Testa
Introduction: Living donor bowel transplantation has recently emerged as a valuable alternative to cadaver bowel transplant. We herein present our single-center experience with this procedure. Materials and Methods: From April 1998 to October 2004, 12 living donor intestinal transplants were performed in 11 patients (7 males, 4 females; average age, 26 years). Four of the patients were children under 5 years. A segment of distal ileum 150 to 180 cm long in pediatric recipients and 200 cm long in adult was used. The immunosuppressive protocol consisted of induction with thymoglobulin and maintenance with tacrolimus with or without mycophenolate mofetil and steroids. Results: All donors recovered well and did not experience any early or late complications. The overall 1- and 3-year patient survival was 82% with a graft survival of 75%. In the last 8 patients, transplanted after January 2000, the 1-year patient and graft survival has been 100% and 88%, respectively. The median hospital stay was 36 days (range, 13–290 days). During the first year after transplant only, the patient who received a totally mismatched graft experienced one episode of rejection (8%). All the surviving patients are currently supported by enteral diet without fluid requirements. Conclusions: Living donor bowel transplantation is a valuable strategy in the treatment of irreversible intestinal failure. The results have improved over the years thanks to increased experience of the team.